“…For example, thiazolidinediones demonstrate detrimental effect on the skeleton and increase fracture risk [ 545 , 599 , 600 , 601 , 602 , 603 , 604 ] but a beneficial effect on muscle atrophy [ 605 ]; other anti-diabetic drugs (sulfonylureas, metformin and possible incretin mimetics) have a neutral or a positive/protective effect on bone health, but they may increase propensity for falls through hypoglycemia (insulin and sulfonylureas) [ 601 , 603 , 604 , 606 ]. When analyzing the complex relationships between OFs and drugs used it should also be taken into account that many medications (corticosteroids, sulfonamides, urea derivatives, vitamin K antagonists, cardiac glycosides, loop diuretics, potassium-sparing diuretics, ACE inhibitors, serotonin reuptake inhibitors, calcium-channel blockers and antiepileptic drugs) may affect the vitamin D status and calcium homeostasis [ 607 , 608 , 609 , 610 , 611 ]. Importantly, even in diseases inversely associated with HPI the abovementioned drugs may contribute to OP and/or falls and should be used with caution, especially in individuals with high fracture risk.…”